An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21

Herpes zoster (HZ) is caused by reactivation of latent varicella-zoster virus (VZV) when VZV-specific cellular immunity is insufficient to control reactivation. Currently, Shingrix, which contains the VZV gE protein and GSK’s AS01(B) adjuvant composed of liposomes formulated with cholesterol, monoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Hyo Jung, Hong, Sung Jun, Lee, Ara, Kim, Jiyeon, Lee, Sangho, Casper, Corey, Carter, Darrick, Reed, Steven G., Simeon, George, Shin, Eui-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033770/
https://www.ncbi.nlm.nih.gov/pubmed/35459225
http://dx.doi.org/10.1038/s41541-022-00467-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033770/
https://www.ncbi.nlm.nih.gov/pubmed/35459225
http://dx.doi.org/10.1038/s41541-022-00467-z

Ejemplares similares